Mon, February 27, 2023

Terence Flynn Maintained (CCCC) at Sell with Decreased Target to $5 on, Feb 27th, 2023

Terence Flynn of Morgan Stanley, Maintained "C4 Therapeutics, Inc." (CCCC) at Sell with Decreased Target from $6 to $5 on, Feb 27th, 2023.

Terence has made no other calls on CCCC in the last 4 months.



There are 3 other peers that have a rating on CCCC. Out of the 3 peers that are also analyzing CCCC, 1 agrees with Terence's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Derek Archila of "Wells Fargo" Maintained at Hold with Decreased Target to $9 on, Tuesday, January 3rd, 2023


These are the ratings of the 2 analyists that currently disagree with Terence


  • Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $35 on, Friday, February 24th, 2023
  • Eric Joseph of "JP Morgan" Downgraded from Hold to Sell and Decreased Target to $5 on, Friday, February 24th, 2023